Improving the production of the micafungin precursor FR901379 in an industrial production strain
Abstract Background Micafungin is an echinocandin-type antifungal agent used for the clinical treatment of invasive fungal infections. It is semisynthesized from the sulfonated lipohexapeptide FR901379, a nonribosomal peptide produced by the filamentous fungus Coleophoma empetri. However, the low fe...
Main Authors: | Ping Men, Yu Zhou, Li Xie, Xuan Zhang, Wei Zhang, Xuenian Huang, Xuefeng Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | Microbial Cell Factories |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12934-023-02050-0 |
Similar Items
-
Establishing an Efficient Genetic Manipulation System for Sulfated Echinocandin Producing Fungus Coleophoma empetri
by: Ping Men, et al.
Published: (2021-08-01) -
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01) -
Micafungin Effectiveness in Treating Pediatric Patients with Proven Candidemia
by: Kamile Ötiken Arıkan, et al.
Published: (2022-12-01) -
Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01) -
Are we near to the end of the standard dose of micafungin?
by: Alexander Agrifoglio, et al.
Published: (2018-06-01)